[fung_derf]

Wow!.....if you are a follower of posters instead of stocks, this one is so much easier to track.
The pumpers come out of the woodworks after Dec. 31 selloff apparently.
But lets give the benefit of the doubt to the company. Current resistance is at .154 (which it is slightly above now). Can it sustain this or is this the selling point?
Next resistance is a bit off at .303 (but dropping).
I'm predicting you all will soon enough watch the stock price drop back down to make a new low, and many of those touting will vanish again for a while.
Just for funsies, save this post and lets all look back in a few months. If I'm wrong I'll say so.....will anyone credit me if I'm right?
I'll bet even today I can name a few here who will deny it.
There is a name for this type trading. Anyone want to guess what its called?

[Niknak1]

Monroe EVERYBODY SHOULD READ THE POZ ARTICLE. A PLETHORA OF INFORMATION. U R A TREMENDOUS RESEARCHER. THUMBS UP TO YOU!!! 👍👍👍

[Niknak1]

Monroe EVERYBODY SHOULD POZ ARTICLE. A PLETHORA OF INFORMATION.

[Monroe1]

With the pps creeping up now 25% green in one of my accounts looking more like anything grabbed under .16 is a huge gift for what is to come.
We would have had approvals already had it not been for the covid scam. I look for those FDA participants to be looking for a job this week as they are the same corrupted officials who emails showed a hateful bias against CytoDyn's Nader, "leronlimab never". Funny, they are both has beens now. It's usually better to make friends even with those who seem opposed. Our current Dr. Jay has this talent.

The US has just dropped out of the WHO who (sounds like an owl hiding in the treetop) supported Dr, Falsi ...pardon the pun, pardoned the pun ??

Remember when !! https://www.poz.com/article/ccr5blocking-antibody-leads-longterm-hiv-suppression
These studies and trials fly in the face of the old FDA. Times have changed perhaps?? Someone knows sumpin is up.
I have full faith some asleep at the wheel will be shocked at what is to come. $$$CYDY$$$ 2025

ps. Meanwhile I am quite exasperated at the lack of pigeon shorts and flippers with wings clipped. So I guess I will buy on the rising market of late.
Pigeons and owls, birds of a feather flock together both chirping in the hospital window, "cheer up, cheer up. we haven't got long".

Dr. The Amazing Dr.Jay....for Jonathan?? A stapler could be what the doctor ordered.

[docj]

You may recognize the authors names of this paper being connected closely to Cytodyn:

https://journals.lww.com/co-hivandaids/abstract/2025/01000/stem_cell_transplantation_and_allogeneic_immunity_.14.aspx

Stem cell transplantation and allogeneic immunity: post treatment control or HIV cure?
Cleary, Megana; Ndhlovu, Lishomwa C.b; Sacha, Jonah B.a,c
Author Information
Current Opinion in HIV and AIDS 20(1):p 86-91, January 2025. | DOI: 10.1097/COH.0000000000000892
Buy

Metrics
Abstract
Purpose of review
Long-lasting HIV remission has been reported in a small group of people with HIV (PWH) following allogenic hematopoietic stem cell transplants (HSCT) for the treatment of hematologic malignancies. While the mechanisms of HIV remission following release from antiretroviral therapy (ART) were not initially known, subsequent findings from clinical cases and preclinical nonhuman primate studies have implicated mechanisms of clearance. Here, we review the six currently published human cases of long-term ART-free HIV remission.

Recent findings
Since the first report of ART-free HIV remission following HSCT, five subsequent cases of HSCT-induced sustained HIV remission have been published. While the pre- and posttransplant treatment conditions vary greatly, all but one received cells from donors homozygous for a 32 bp deletion in the gene that encodes CCR5 (ccr5?32), the major HIV coreceptor. Studies in nonhuman primates and the newest published individual suggest that while CCR5 deficiency can protect donor cells from infection early posttransplant, it is not required for long term remission, as ablation of the viral reservoir is likely due to allogeneic immunity mediating a graft-versus-reservoir response.

Summary
Studies of HSCT in PLWH and simian immunodeficiency virus (SIV)-infected monkeys show that those with durable remission are likely cured, demonstrated by complete ablation of the replication-competent HIV reservoir, gradual loss of anti-HIV immunity, and greater than 5 years of aviremia.

[Monroe1]

One big step forward in the right direction.
https://petermcculloughmd.substack.com/p/breaking-trump-signs-executive-order#media-ced0166e-34f0-4cfe-a67f-649bbc1d30dd

Change is happening now. As it comes ushering in real science and not political science to lead the way as it should be, as it once was
long ago before being hijacked.

May leronlimab lead the way for all the beneficial monoclonal antibodies getting a foothold. How many millions of lives could have been
saved already?

$$$CYDY$$$ 2025

[Monroe1]

Great update synopsis for the HIV indication. Add that to the others being pursued and what is not to like about this stock these days.
We could go to a dollar a share in the blink of an eye for any one of the indications being studied especially when another company or
university wants to participate and foot the bill like was mentioned in the end of the year update.

[docj]

He follows with:

MGK2
Yesterday 4:34 PM

Funded by BMGF, a human trial that determines if CURING HIV through Triple Therapy is statistically clinically significant, then pushing for FDA approval. BMGF, through Max, gets access to long-acting leronlimab, PrEP as well. They get access to AAV-CURE. They get access to Scott Hansen's work with the 3rd party AI development collaborator. Human Trials are coming folks, but the main one that I'm looking at right now is the one I discussed here in this post. Triple Therapy for CURE. That BMGF sponsored Human Trial gets CytoDyn through the next few years until the completion of the MSS mCRC clinical trial and everything else that it is slated to do in the next few years.

[docj]

Another nugget to ponder from MGK2:

MGK2
Yesterday 4:32 PM

$CYDY
reddit.com/r/Livimmune/comm...

BMGF helps secure their own leadership towards an HIV Cure by bringing in Max Lataillade, DO funding his vision which aims to Cure HIV. Max left ViiV to come to CytoDyn because of leronlimab. Max knew that an HIV Cure was imbedded into leronlimab which blocks the CCR5 doorway that HIV uses to enter CD4 T Cells. He knew he needed to be planted at the company who owned the molecule. The GF hears and considers this molecule with Max at the head of the initiative.

Max knew, he could not eradicate HIV without leronlimab. He also knew that BMGF could not eradicate HIV without leronlimab. Somehow, Max brought the plan to BMGF and it has been codified. Now the thinking is how much is coming? Hundreds of millions is my answer. Nobody has cured HIV. Nobody that is until STEM Cell transfer. AAV is also coming close, but work yet has to be done on that initiative. However, Triple Therapy has done it and now BMGF and Max Lataillade start the human trial.

[chumppunk]

docj- your posts and monroe1 are two I always read. Keep it up they are always on topic and thanks.
Chump

[docj]

Here is a post from another board I think you will appreciate. One of the most liked posts of all time . Viewed a ton. Thanks to mightycvdy!:

Bill Gates mentions accelerated rollout of HIV cure

For those who haven't been following closely, CYDY recently added HIV expert Dr. Max Lataillade as "Senior Vice President and Head of Clinical Development". Details here:
https://www.cytodyn.com/newsroom/press-releas...enior-vice

On the very same day that Dr. Max updated his Linkedin page by adding his new role at CYDY, Dr. Max also announced his new role as "Head of HIV Drug Development Bill & Melinda Gates Foundation". Details here:
https://www.linkedin.com/in/maxlataillade/

This is worth reading (key excerpt: "This led the researchers to determine that stopping HIV from using the CCR5 receptor to infect donor cells is also needed for a cure to occur."
https://news.ohsu.edu/2023/05/25/ohsu-researc...-in-people

Also worth reading:
https://www.biospace.com/cytodyn-highlights-n...leronlimab

And:
https://www.cytodyn.com/newsroom/press-releas...eronlimabs

Now check out this (new) two-minute video interview where Bill Gates talks about the Gates foundation currently developing a cure for HIV and the possibility of rolling it out at an accelerated pace:

https://www.wsj.com/politics/policy/bill-gate...g-e54fc20d

Hopefully CYDY's Leronlimab will play a major role in the HIV Cure that the Gates foundation is developing and planning to rollout in the near future. In addition to saving countless lives, this is noteworthy (per ChatGPT): "According to recent market reports, the global HIV drugs market is currently valued at around $33 billion and is expected to reach approximately $49.68 billion by 2032, growing at a CAGR of 4.3% with combination-class drugs dominating the market share; this indicates a substantial market for HIV treatments, although a true "cure" is not yet widely available."

Excerpted from CYDY's website:
"...Leronlimab is being studied for HIV... Leronlimab is a competitive rather than allosteric inhibitor of the CCR5 receptor. We believe this mechanism of action, of binding competitively to the CCR5 receptor, differentiates leronlimab from all other CCR5 antagonists."

"Leronlimab belongs to a class of HIV therapies known as viral entry inhibitors that block HIV from entering and infecting healthy cells. In illustrating the importance of CCR5 in HIV, individuals that lack CCR5 expression due to a natural genetic mutation are naturally resistant to HIV infection. Today, six people have been cured of HIV who were given transplanted cells either completely or partially deficient in the CCR5 receptor."

"CytoDyn is currently evaluating the potential role of leronlimab in achieving an HIV cure."

I remain... #BULLISH

*Disclaimer regarding the above speculative opinion post; I only have access to the same exact publicly available information as everyone else and am simply trying to connect some dots. None of the above should be taken as investment advice.

[moneycrew]

tuesday is when it all changes...BIG TIME

[Monroe1]

I do love my long weekends especially this one... so many good things on the horizon for CytoDyn especially with the changes coming to our health care system.
So Univ of Missouri? Or Icahn School of Medicine?

I nominate Senator Rory Blunt for a Director's seat on the CytoDyn board. Maybe the Rory Blunt Lab will "show me" the state of affairs. Mizzou will help fund the fibrosis MASH study? Could be.

Seems to be a liking going on for Denmark and Novo Nordisk is on a buying tear. Eli Lily in hot pursuit. Other MASH players
jumping on the metabolic weight scale too. Will one give a wink to CytoDyn due to this weight loss fibrosis hunt? Let me say this,
sing it loud and sing it proud should we all of a sudden be in the big game. Stranger things have happened and we are certainly in strange times.

Don't give away the farm Dr. Jay.
$$$CYDY$$$ 2025

[Since 2012]

My God, a three year old can predict a penny stock fluctuating, you aren’t very smart is the reason nobody listens to you, nobody has sold a single share because of you, nobody, not one, very few people read charts FF

[docj]

PSA:


All major U.S. stock markets will be closed on Monday January 20, in observance of Martin Luther King Jr. Day.

[fung_derf]

It was made up from the CEO and posters here. Don't understand how you now can't see that.
Aren't they back at Phase 1 of medical trials?
I'm only biased based on facts. The "bad actors" make money on each of the pumps....and dumps. All you need to know is how to read a stock chart, and observe the volume and trend in trading.
How many times do I need to predict accurately where the price will rise and fall to before people learn to listen?

[big bopper1]

I believe we have a good drug,but at this point,we need to have clinical trials to scientifically prove it.

[docj]

Sorry when you make such a blanket statement such as "But none of it was true, was it?" I must completely disregard your posts.

There is significant CYDY news coming. Some might even be shocked.

[bwolfy2002]

How stupidly simplistic and wrong. Of course some of it was true. LL is a real drug with real results that thousands of people have taken. 

Anyone as biased as you should at least understand that bad actors often times effectively misuse truth. 

[big bopper1]

Your probably correct,but those were reasons it went up. Now we need a real trial with real results. Hopefully,they will design trial correctly

[docj]

For those interested in reading posts from MGK_2:

https://www.reddit.com/r/Livimmune/comments/1i33nxw/games_people_play/

[fung_derf]

But none of it was true, was it?
Pumps and dumps abound.

[big bopper1]

There have been a few reasons stock has gone up. Investors believed that we were goint to get final ok for aids. Another time was covid trials ,and doctors who believed drug would work.

[fung_derf]

Based on your logic, why has the stock price EVER moved? The company has NEVER produced anything. So tell me, what could have possibly made the stock move in price over the years? I know you can get this one!

[Monroe1]

The Company will be prioritizing oncology in 2025, as we believe this indication holds the potential for the highest value return to the Company in the form of a significant partnership and/or drug approval. As recently announced, CytoDyn has received FDA clearance to initiate a Phase II study of leronlimab in patients with relapsed/refractory micro-satellite stable colorectal cancer (CRC). As noted in our prior release, we recently completed the kickoff meeting with Syneos Health, the CRO for the study, and enrollment efforts are set to begin in January. .............

......The second follow-up study involves the administration of CCL4, a drug that directly causes liver fibrosis in mice. This study will clarify if the observed reversal of liver fibrosis is restricted to the MASH/fat deposition pathway or might occur independently of the etiology of fibrosis (e.g. alcohol, viral hepatitis, etc.). The results from both follow-up studies will become available in January. As a side note, we have been contacted by colleagues at a major academic institution who indicated that, if the liver fibrosis reversal results are confirmed in the follow-up studies, they would be interested in funding a pilot study of leronlimab in the treatment of patients with pulmonary fibrosis at their own center.

Some have postulated that this second follow-up study may bring a very surprising update... maybe before month end????? OMG
$$$CYDY$$$ New collaborator coming?... maybe more!! Standing by for the rest of the story.

Hurry Pigeons... get me some more cheapies and step on it. Times a wasting. You sick birds are falling down on the job.

[big bopper1]

Of course, there are other things like buyout,but this stock has been in a small range for awhile. It will continue this range until news one way or another

[docj]

10Q

https://www.cytodyn.com/investors/sec-filings/all-sec-filings/content/0001558370-25-000207/0001558370-25-000207.pdf

[docj]

very simplistic viewpoint you promote. I can think of several reasons why the stock could move besides the initiaton of a human trial if that is what you mean.

[big bopper1]

Short or long there is no reason for stock to go up or down. If trials actually commence,then this would be a more optomisic time. If they dont start,this would create negativity.

[kgromax]

MGK_2 is a case study in being always wrong, regarding his Cytodyn & Leronlimab analysis capabilities. A good example to (not) follow.

His past Reddit messages, all his messages, all demonstrate the same thing : his "sure things" never occur, and the contrary ends up crashing the company's stock price. Dozens of example. It's like watching a car crash rolling over repeatedly...he seems to have a knack for this. This poor MGK_2 thing, when will the suffering stop

[Monroe1]

Looks like the ShortyFlips have taken the off-ramp. Come on back pigeons, don't fly away on me now!!
All together now, give it your best shot. And hurry, money is burning a hole in my pocket.
Talk about more old Nada stuff or hammer on Tanya. Something effective must be in your bag of tricks somewhere.

Will we see a magical moment with Madrigal?

$$$CYDY$$$ 2025

[docj]

From MGK_2:

https://www.reddit.com/r/Livimmune/comments/1i13186/off_ramp/

[fung_derf]

If you thought the stock was truly going up, it wouldn't matter. This still hasn't broken through resistance. Perhaps you don't believe it can.
Anyone who thinks this stock is going to rocket isn't worried about saving tenths of cents.
Are you sure you want to blame others? Your excuses appear quite lame

[Monroe1]

My God pigeons it's Monday, so do your job. How do you expect me to accumulate more shares with your pathetic excuses. Get to graveling!!
Time is running out.

[Monroe1]

Inching up on volume and pps. A bit higher on highs and higher lows as accumulation continues. And why not?
Nice strong close on Friday. The MM's are managing the pps to the upside now.